Skip to main content

ADVANCED ENERGY INDUSTRIES INC

For the period ended Dec 31, 2025. Filed Feb 13, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Feb 13, 2026

AEIS$219.30+11.3%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Notes to Consolidated Financial Statements

NOTE 1. SUMMARY OF OPERATIONS AND SIGNIFICANT ACCOUNTING POLICIES AND ESTIMATES

Advanced Energy Industries, Inc., a Delaware corporation, and its consolidated subsidiaries (“we,” “us,” “our,” “Advanced Energy,” or the “Company”) provides highly engineered, critical, precision power conversion, measurement, and control solutions to our global customers. We design, manufacture, sell and service precision power products that transform, refine, and modify the raw electrical power coming from either the utility or the building facility and convert it into various types of highly controllable, usable power that is predictable, repeatable, and customizable to meet the necessary requirements for powering a wide range of complex equipment. Many of our products enable customers to reduce or optimize their energy consumption through increased power conversion efficiency, power density, power coupling, and process control across a wide range of applications.

In December 2015, we completed the wind down of engineering, manufacturing, and sales of our solar inverter product line. We have continuing involvement with regard to certain warranty obligations. Accordingly, the results of our inverter business are reflected as loss from discontinued operations, net of income taxes on our Consolidated Statements of Operations.

During 2025, we changed the presentation of our financial statements and accompanying footnote disclosures from thousands to millions. This change did not materially impact previously reported financial information.

Principles of Consolidation

Our consolidated financial statements include the Company and its subsidiaries. All intercompany accounts and transactions have been eliminated. Our consolidated financial statements are stated in United States (“U.S.”) Dollars and have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”).

Use of Estimates in the Preparation of the Consolidated Financial Statements

The preparation of our consolidated financial statements in conformity with U.S. GAAP requires us to make estimates, assumptions, and judgments that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. The significant estimates, assumptions, and judgments include, but are not limited to, excess and obsolete inventory, income taxes and other provisions, and acquisitions and asset valuation.

Segment Information

Our Chief Executive Officer (“CEO”) is the chief operating decision maker who reviews financial information on a consolidated basis for purposes of allocating resources and evaluating financial performance. Accordingly, we determined we operate in a single reporting segment – power electronics conversion products. Within this segment, our products are sold into the Semiconductor Equipment, Data Center Computing, Industrial and Medical, and Telecom and Networking markets.

Our CEO assesses performance and decides how to allocate resources primarily based on consolidated net income, which is reported on our Consolidated Statements of Operations. Total assets on the Consolidated Balance Sheets represent our segment assets.

Foreign Currency Translation

The functional currency of certain of our foreign subsidiaries is the local currency. Assets and liabilities of these foreign subsidiaries are translated to the United States Dollar at prevailing exchange rates on the balance sheet date.

Revenues and expenses are translated at the average exchange rates in effect for each period. Translation adjustments resulting from this process are reported as a separate component of other comprehensive income.

For certain other subsidiaries, the functional currency is the U.S. Dollar. Foreign currency transactions are recorded based on exchange rates at the time such transactions arise. Subsequent changes in exchange rates for foreign currency denominated monetary assets and liabilities result in foreign currency transaction gains and losses, which are reflected as unrealized (based on period end remeasurement) or realized (upon settlement of the transactions) in other income (expense), net in our Consolidated Statements of Operations.

Derivatives

We use derivative financial instruments to manage risks associated with foreign currency. Unless we meet specific hedge accounting criteria, changes in the fair value of derivative financial instruments are recognized in the Consolidated Statements of Operations within other income (expense), net.

Fair Value

We value certain financial assets and liabilities using fair value measurements.

U.S. GAAP for fair value establishes a hierarchy that prioritizes fair value measurements based on the types of inputs used for the various valuation techniques (market approach, income approach, and cost approach). Our financial assets and liabilities are measured using inputs from the three levels of the fair value hierarchy. The three levels of the hierarchy and the related inputs are as follows:

●Level 1 — Quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access on the measurement date.
●Level 2 — Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.
●Level 3 — Unobservable inputs for the asset or liability.

We categorize fair value measurements within the fair value hierarchy based upon the lowest level of the most significant inputs used to determine fair value. Our assessment of the significance of a particular input to the fair value measurement requires judgment and may affect the valuation of the fair value of assets and liabilities and their placement within the fair value hierarchy levels.

We have various assets and liabilities measured at fair value on a recurring basis, including:

​​​​​​​
Category of Asset or Liability​Fair Value Hierarchy​Methodology for Estimating Fair Value
Certificates of deposit and investments​​Level 2​Observable market data for similar assets
Foreign currency forward contracts ​​Level 2​Forecasted movement in the forward rates of foreign currency for the applicable duration in which the hedging instrument is denominated
Deferred compensation liability​Level 2​Observable market data for participants’ notional funds
Pension benefit obligations​​Level 2​Actuarial analysis, which includes various estimates and assumptions including, but not limited to, discount rates, expected return on plan assets, and future inflation rates

The carrying amounts of our cash and cash equivalents, accounts receivable, accounts payable and other current assets and liabilities approximate fair value as recorded due to the short-term nature of these instruments.

Our non-financial assets, which primarily consist of property and equipment, operating lease right-of-use assets, goodwill, and other intangible assets, are not required to be carried at fair value on a recurring basis and are reported at carrying value. However, on a periodic basis or whenever events or changes in circumstances indicate that their carrying value may not be fully recoverable (and at least annually for goodwill), non-financial instruments are assessed for impairment and, if applicable, written down to and recorded at fair value. SeeNote 5. Intangible Assets and Goodwill for further discussion and presentation of these amounts.

Cash and Cash Equivalents

We consider all amounts on deposit with financial institutions and highly liquid investments with an original maturity of three months or less at the time of purchase to be cash equivalents. Cash and cash equivalents consist primarily of short-term money market instruments and demand deposits with insignificant interest rate risk.

In some instances, we invest excess cash in money market funds not insured by the Federal Deposit Insurance Corporation. The investments in money market funds are on deposit with credit-worthy financial institutions and the funds are highly liquid. These investments are reported at fair value and included in cash and cash equivalents.

We classify investments with stated maturities of greater than three months at time of purchase in other current assets on the Consolidated Balance Sheets.

Concentrations of Credit Risk

Financial instruments with potential credit risk include cash and cash equivalents and trade accounts receivable. To preserve capital and maintain liquidity, we invest with financial institutions we deem to be of high quality and sound financial condition. Our investments are in low-risk instruments, and we limit our credit exposure in any one institution or type of investment instrument based upon criteria, including creditworthiness.

Allowance for Credit Losses

We evaluate collection risk and establish expected credit loss primarily through a combination of the following: continuous monitoring of customer credit, analysis of historical aging and credit loss experience, current economic conditions, and customer specific information.

Our standard payment terms are net 30 days. Certain large volume customers have longer payment terms. Generally, we do not require collateral from customers.

Inventories

We value inventories at the lower of cost or net realizable value, computed on a first-in, first-out basis. General market conditions, as well as our design activities, can cause certain products to become obsolete and we adjust our inventory carrying value for estimated excess and obsolescence equal to the difference between the cost of inventory and the estimated net realizable value based on projected end-user demand, which is determined by considering historical usage, customer orders and forecast, and qualitative considerations such as market and economic conditions. The determination of projected end-user demand requires the use of estimates and assumptions related to projected unit sales for each product. Demand for our products can fluctuate significantly. A significant decrease in demand could result in an increase in the charges for excess inventory quantities on hand.

Property and Equipment

Property and equipment are stated at cost or estimated fair value if acquired in a business combination. We compute depreciation over the estimated useful lives using the straight-line method. Additions and improvements are capitalized, while maintenance and repairs are expensed as incurred. We evaluate the useful life and test for impairment whenever events or changes in circumstances indicate the carrying amount of an asset group containing the property and equipment may not be recoverable.

When depreciable assets are retired, or otherwise disposed of, the cost and related accumulated depreciation are removed from the accounts, and any related gains or losses are included in other income (expense), net, in our Consolidated Statements of Operations.

Internal-Use Software Development Costs

We capitalize qualifying costs associated with software applications developed for internal use. We begin capitalization after meeting two criteria: (i) the preliminary project stage is completed and (ii) it is probable that the software will be completed and used for its intended function. We also capitalize costs related to specific upgrades and enhancements when it is probable the expenditures will result in significant additional functionality. We cease capitalization when the software is substantially complete and ready for its intended use, including the completion of all significant testing.

Costs related to preliminary project activities, post-implementation operating activities, maintenance, and minor upgrades are expensed as incurred.

We classify capitalized software development costs within property and equipment, net and other assets on the Consolidated Balance Sheets. These costs are amortized on a straight-line basis over the software’s estimated useful life. Amortization is included in both cost of revenue and operating expenses. We evaluate the useful life and test for impairment whenever events or changes in circumstances indicate the carrying amount may not be recoverable.

Leases

We lease manufacturing and office space under non-cancelable operating leases. Some of these leases contain provisions for landlord funded leasehold improvements, which we record as a reduction to right-of-use (“ROU”) assets and the related operating lease liabilities. Our lease agreements generally contain lease and non-lease components, and we combine fixed payments for non-lease components with lease payments and account for them together as a single lease component. Certain lease agreements may contain variable payments, which are expensed as incurred and not included in the right-of-use lease assets and operating lease liabilities. When renewal options are reasonably certain of exercise, we include the renewal period in the lease term. In many cases, we have leases with a term of less than one year. We elected the practical expedient to exclude these short-term leases from our ROU assets and operating lease liabilities. On an ongoing basis, we negotiate and execute new leases to meet business objectives.

Right-of-use assets and operating lease liabilities are recognized at the present value of the future lease payments on the lease commencement date. The interest rate used to determine the present value of the future lease payments is our incremental borrowing rate because the interest rate implicit in our leases is not readily determinable. Our incremental borrowing rate is estimated to approximate the interest rate on a collateralized basis with similar terms and payments. We have a centrally managed treasury function; therefore, we apply a portfolio approach for determining the incremental borrowing rate applicable to the lease term. Operating lease expense is recognized on a straight-line basis over the lease term.

We evaluate the useful life and test for impairment whenever events or changes in circumstances indicate the carrying amount of an asset group containing the right-of-use assets may not be recoverable.

Intangible Assets and Goodwill

Our intangible assets consist of customer relationships, developed technology, trademarks, patents, and intellectual property, which are stated at cost less accumulated amortization. Intangible assets, which are considered long-lived assets, are amortized over their estimated useful lives and reviewed for impairment when events or changes in circumstances indicate that the carrying amount of an asset group containing these assets may not be recoverable.

Goodwill represents the excess of the purchase price over the fair value of the identifiable net assets acquired in a business combination. We evaluate goodwill for impairment as a single reporting unit annually during the fourth quarter or when events or changes in circumstances indicate the carrying value may not be recoverable.

Our goodwill impairment evaluation consists of a qualitative assessment. If this assessment indicates it is more likely than not that the Company’s estimated fair value exceeds the carrying value of our net assets, we do not consider goodwill to be impaired. Otherwise, we perform a quantitative assessment by comparing the Company’s fair value to the carrying value of our net assets, including goodwill. If the carrying value of our net assets exceeds the fair value, we consider goodwill to be impaired.

Based on the facts and circumstances, we determine the fair value based on an income, market, or cost approach. Each method is subjective in nature and involves the use of significant estimates and assumptions, which can include projected financial results, discount rates, long-term growth rates, and industry trends.

We determined that there were no indicators of impairment of our long-lived intangible assets or goodwill during the year ended December 31, 2025.

Debt Issuance Costs

We capitalize costs associated with issuing debt. Depending on the nature of the agreement, we record these costs on the Consolidated Balance Sheets either in other assets or as a direct deduction from the carrying amount of the debt. We amortize the costs over the term of the agreement using the effective interest method. Amortization expense is reflected within interest expense on the Consolidated Statements of Operations. SeeNote 7. Long-Term Debt for additional details.

Revenue Recognition

Net revenue consists of products and support services.

We recognize substantially all revenue at a point in time when we satisfy our performance obligations. Typically, this occurs on shipment of goods because, at that point, we transfer control to our customer. The transaction price is based upon the standalone selling price. In most transactions, we have no obligations to our customers after the date products are shipped, other than pursuant to warranty obligations. We recognize revenue net of any taxes collected from customers, which are subsequently remitted to governmental authorities. Surcharges, cost recoveries, and shipping and handling fees billed to customers, if any, are recognized as revenue. The related cost for shipping and handling fees is recognized in cost of revenue.

Support services include warranty and non-warranty repair services, upgrades, and refurbishments on the products we sell. Repairs covered under our standard warranty do not generate revenue. We recognize substantially all non-warranty revenue upon completion of the service because that is the point in time when we satisfy our performance obligation.

As part of our ongoing service business, we satisfy our service obligations under preventative maintenance contracts and extended warranties. Up-front fees received for extended warranties or maintenance plans are deferred and recorded in customer deposits and other on the Consolidated Balance Sheets. Revenue under these arrangements is recognized ratably over the underlying terms, as we do not have historical information that would allow us to project the estimated service usage pattern at this time.

We expense the incremental costs of obtaining contracts when the amortization period of the costs is less than one year. These costs are included in selling, general, and administrative expenses in our Consolidated Statements of Operations.

Our remaining performance obligations primarily relate to customer purchase orders for products we have not yet shipped. We expect to fulfill the majority of these performance obligations within one year.

Research and Development Expenses

Costs incurred to advance, test, or otherwise modify our technology or develop new technologies are considered research and development costs and are expensed when incurred. These costs are primarily comprised of costs associated with the operation of our laboratories and research facilities, including internal labor, materials, and overhead.

Stock-Based Compensation

Accounting for stock-based compensation requires the measurement and recognition of compensation expense for all stock-based awards made to employees and directors based on estimated fair value at the grant date.

We estimate the fair value of restricted stock units (“RSUs”) on the grant date. For RSUs that contain a time-based and certain performance-based vesting condition, we calculate fair value using the closing share price on the grant date.

We record stock-based compensation expense for awards with time-based vesting conditions on a straight-line basis over the requisite service period. For awards with a performance-based vesting condition, we record stock-based compensation expense (based on our assessment of the probability of meeting the performance conditions) over the estimated period to achieve the performance conditions. If the awards are forfeited, we reverse the stock-based compensation expense.

Certain RSUs vest based on a market condition. Our stock-based compensation expense is based on an estimate of the fair value and probability of achievement for each tranche of these awards using a Monte Carlo simulation. For these RSUs, we recognize stock-based compensation expense over each tranche’s estimated achievement period even if some or all of the shares never vest.

For all stock awards, we estimate forfeitures at the grant date and revise those estimates in subsequent periods if actual forfeitures differ from our estimates.

Income Taxes

We follow the liability method of accounting for income taxes under which deferred tax assets and liabilities are recognized for future tax consequences. A deferred tax asset or liability is computed for both the expected future impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carryforwards. Tax rate changes are reflected in the period such changes are enacted.

We assess the recoverability of our net deferred tax assets and the need for a valuation allowance on a quarterly basis. Our assessment includes several factors, including historical results and taxable income projections for each jurisdiction. The ultimate realization of deferred income tax assets is dependent on the generation of taxable income in appropriate jurisdictions during the periods in which those temporary differences are deductible. We consider the scheduled reversal of deferred income tax liabilities, projected future taxable income, and tax planning strategies in determining the amount of the valuation allowance. Based on the level of historical taxable income and projections for future taxable income over the periods in which the deferred income tax assets are deductible, we determine if we will more likely than not realize the benefits of these deductible differences.

Accounting for income taxes requires a two-step approach to recognize and measure uncertain tax positions. The first step is to evaluate the tax position for recognition by determining, if based on the technical merits, it is more likely than not that the position will be sustained upon audit, including resolutions of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon ultimate settlement. We regularly assess the likelihood of favorable or unfavorable outcomes resulting from these examinations to determine the adequacy of our provision for income taxes. This evaluation is based on factors including, but not limited to, changes in facts or circumstances, changes in tax law, effectively settled issues under audit, and new audit activity.

Under U.S. GAAP, an accounting policy election can be made to either recognize deferred taxes for temporary basis differences expected to reverse as global intangible low-tax income (“GILTI”) in future years, or to provide for the tax expense related to GILTI in the year that the tax is incurred as a period expense only. We have elected to account for GILTI in the year that the tax is incurred.

Commitments and Contingencies

We are involved in disputes and legal actions arising in the normal course of our business. While we currently believe that the amount of any ultimate loss would not be material to our financial position, the outcome of these actions is inherently difficult to predict. In the event of an adverse outcome, the ultimate loss could have a material adverse effect on our financial position or reported results of operations. An unfavorable decision in intellectual property litigation also could require material changes in production processes and products or result in our inability to ship products or components found to have violated third party intellectual property rights. We accrue loss contingencies in connection with our commitments and contingencies, including litigation, when it is probable that a loss has occurred, and the amount of such loss can be reasonably estimated. We are not currently a party to any legal action that we believe would reasonably have a material adverse impact on our business, financial condition, results of operations or cash flows.

New Accounting Standards

From time to time, the Financial Accounting Standards Board (“FASB”) or other standards setting bodies issue new accounting pronouncements. Updates to the FASB Accounting Standards Codification (“ASC”) are communicated through issuance of an Accounting Standards Update (“ASU”). Unless otherwise discussed, we believe that the impact of recently issued guidance, whether adopted or to be adopted in the future, will not have a material impact on the consolidated financial statements upon adoption.

New Accounting Standards Adopted

In December 2023, the FASB issued ASU 2023-09 “Income Taxes (Topic 740): Improvements to Income Tax Disclosures.” ASU 2023-09 requires disaggregated information about a reporting entity’s effective tax rate reconciliation as well as additional disclosure on income taxes paid. We adopted this guidance for the year ending December 31, 2025 and have provided the required disclosures. SeeNote 14. Income Taxes.

New Accounting Standards Issued But Not Yet Adopted

In November 2024, the FASB issued ASU 2024-03*“Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses.”* ASU 2024-03 requires disaggregated disclosure of income statement expenses for public business entities. The ASU does not change the expense captions an entity presents on the face of the income statement; rather, it requires disaggregation of certain expense captions into specified categories in disclosures within the footnotes to the financial statements. This guidance will be effective for us on January 1, 2027. We do not expect the above guidance to materially impact our consolidated financial statements.

In July 2025, the FASB issued ASU 2025-05*“Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets.”* ASU 2025-05 permits the use of certain estimates and assumptions in developing forecasts used for determining expected credit losses on accounts receivable. This guidance will be effective for us on January 1, 2026. We do not expect the above guidance to materially impact our consolidated financial statements.

In September 2025, the FASB issued ASU 2025-06*“Intangibles – Goodwill and Other - Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software.”* ASU 2025-06 eliminates the consideration of project development stages in determining whether a cost is eligible for capitalization. Instead, cost capitalization will be based on a “probable to complete” threshold. This guidance will be effective for us on January 1, 2028. We are evaluating the impact, if any, that the adoption of ASU 2025-06 may have on our consolidated financial statements.

NOTE 2. ACQUISITION

On June 20, 2024, we acquired 100% of the issued and outstanding shares of capital stock of Airity Technologies, Inc. (“Airity”). We accounted for this transaction as a business combination. This acquisition added high voltage power conversion technologies and products, broadening our range of targeted applications within the Semiconductor Equipment and Industrial and Medical markets.

The following table summarizes the consideration paid:

​​​​
​ · ​ · Consideration
​ · ​ · (in millions)
Cash paid at closing​$14.3
Advanced Energy common stock​​4.5
Settlement of payables​​(0.7)
Indemnity holdback payable on the one-year anniversary​​1.5
Total fair value of purchase consideration​$19.6

We allocated the purchase price consideration to the assets acquired and liabilities assumed based on their estimated fair values as of the acquisition date, with the excess allocated to goodwill. The following represents the final purchase price allocation.

​​​​
​ · ​ · Fair Value
​ · ​ · (in millions)
Cash​$0.5
Current assets and liabilities, net​​0.5
Deferred tax liability​​(1.7)
Intangible assets​​4.2
Goodwill (not deductible for tax purposes)​​16.1
Total fair value of net assets acquired​$19.6

We included Airity’s results of operations in our consolidated financial statements from the date of acquisition, which were not material.

In connection with the acquisition, we entered into agreements with certain former Airity employees. On the closing date, these individuals received a total of 0.1 million shares of Advanced Energy common stock valued at $15.6 million based on the June 20, 2024 closing price, of which $4.5 million was allocated to purchase consideration and $11.1 million will be future compensation. We will record the $11.1 million as stock-based compensation expense over thethree-year expected vesting period. See* Note 13. Stock-based Compensation*.

During 2025, we paid $1.5 million in connection with the release of the indemnity holdback. See our Consolidated Statements of Cash Flows.

NOTE 3. REVENUE

Disaggregation of Revenue

The following tables present additional information regarding our revenue:

Revenue by Market

​​​​​​​​​​
​ · ​ · Years Ended December 31,
​ · ​ ​ ​ · 2025 · ​ ​ ​ · 2024 · ​ ​ ​ · 2023
​ · ​ · (in millions)
Semiconductor Equipment​$839.9​$792.5​$743.8
Data Center Computing​​587.3​​284.2​​249.9
Industrial and Medical​282.3​316.2​474.4
Telecom and Networking​​89.3​​89.1​​187.7
Total​$1,798.8​$1,482.0​$1,655.8

Revenue by Significant Countries

​​​​​​​​​​​​​​​​​
​ · ​ · Years Ended December 31,
​ · ​ ​ ​ · 2025 · ​ ​ ​ · 2024 · ​ ​ ​ · 2023
​ · ​ · (in millions) · ​
United States​$541.4​30.1%$508.7​34.3%$598.4​36.1%
Mexico​​252.8​14.1​​160.1​10.8​​123.5​7.5​
Taiwan​​130.2​7.2​​159.6​10.8​​124.2​7.5​
Japan​​218.2​12.1​​53.6​3.6​​62.5​3.8​
All others​​656.2​36.5​​600.0​40.5​​747.2​45.1​
Total​$1,798.8​ ​ ​100.0%$1,482.0​ ​ ​100.0%$1,655.8​ ​ ​100.0%

We attribute revenue to individual countries and regions based on the customer’s ship to location. Aside from the specific countries listed above, no individual country exceeded 10% of our total consolidated revenues during the periods presented.

Revenue by Category

​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​
​ · ​ · Years Ended December 31,
​ · ​ ​ ​ · 2025 · ​ ​ ​ · 2024 · ​ ​ ​ · 2023
​ · ​ · (in millions)
Product​$1,614.9​$1,315.7​$1,484.0
Services and other​​183.9​166.3​171.8
Total​$1,798.8​ ​ ​$1,482.0​ ​ ​$1,655.8

Other revenue includes certain spare parts and products sold by our service group.

Significant Customers

During the year ended December 31, 2025, three customers accounted for 23%,19%, and 12% of our total revenue, respectively. During the year ended December 31, 2024, two customers accounted for 26% and 11% of our total revenue, respectively. During the year ended December 31, 2023, one customer accounted for 22% of our total revenue.

As of December 31, 2025, the account receivable balance from three customers accounted for 26%,10%, and 20%, respectively, of our total accounts receivable. During the year ended December 31, 2024, two customers accounted for 25% and 14%, respectively, of our total accounts receivable. No other customer’s account receivable exceeded 10% of our total accounts receivable in the periods presented.

NOTE 4. BALANCE SHEET INFORMATION

Accounts Receivable, Net

We record accounts receivable at net realizable value. Our accounts receivable, net balance on the Consolidated Balance Sheets was $325.2 million at December 31, 2025. The following table summarizes the changes in expected credit losses related to receivables:

​​​​​​​​​​
​ · ​ · Years Ended December 31,
​ · ​ ​ ​ · 2025 · ​ ​ ​ · 2024 · ​ ​ ​ · 2023
​ · ​ · (in millions)
Balance at beginning of period​ ​$0.9​$1.7​$1.8
Additions​—​​0.1​0.2
Deductions - write-offs and other adjustments​​(0.3)​​(0.9)​​(0.3)
Balance at end of period​$0.6​$0.9​$1.7

Inventories

We value inventories at the lower of cost or net realizable value, computed on a first-in, first-out basis. Components of inventories were as follows:

​ · ​ · ​ · ​ · ​ · ​ · ​
​ · ​ · December 31,
​​ ​ ​2025​ ​ ​2024
​ · ​ · (in millions)
Parts and raw materials​$313.6​$255.1
Work in process​27.3​20.6
Finished goods​70.3​84.7
Total​$411.2​$360.4

Property and Equipment, Net

Property and equipment, net increased $87.2 million due to continued investment in our new ERP system, expanding capacity in our existing factories, and our new factory in Thailand. Property and equipment, net is comprised of the following:

​​​​​​​​​
​ · ​ · Estimated Useful · ​ · December 31, · ​ · December 31,
​ · ​ ​ ​ · Life (in years) · ​ ​ ​ · 2025 · ​ ​ ​ · 2024
​ · ​ · ​ · ​ · (in millions)
Buildings, machinery, and equipment​5 to 25​$241.4​$196.6
Software​3 to 10​​40.7​​35.6
Computer equipment, furniture, fixtures, and vehicles​3 to 5​31.0​26.0
Leasehold improvements​2 to 10​101.0​93.0
Capital projects in process​​​82.5​35.4
​​​​496.6​386.6
Less: Accumulated depreciation​​​(223.8)​(201.0)
Property and equipment, net​​​$272.8​$185.6

The following table summarizes property and equipment, net by geographic area:

​​​​​​​
​ · ​ · December 31,
​ · ​ ​ ​ · 2025 · ​ ​ ​ · 2024
​ · ​ · (in millions)
United States​$107.6​$83.8
Asia​​146.4​​87.8
Europe and other​​18.8​​14.0
Total​$272.8​$185.6

The following table summarizes depreciation expense. All depreciation expense is recorded in income from continuing operations:

​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​
​ · ​ · ​ · Years Ended December 31,
​​ ​ ​​2025​ ​ ​2024​ ​ ​2023
​ · ​ · ​ · (in millions)
Depreciation expense​​$39.8​$42.5​$38.3

Warranties

Our sales agreements include customary product warranty provisions, which generally range from 12 to 36 months after shipment. We record the estimated warranty obligations cost when we recognize revenue. This estimate is based on historical experience by product.

Our estimated warranty obligation is included in other accrued expenses in our Consolidated Balance Sheets. Changes in our product warranty obligation were as follows:

​ · ​ · ​ · ​ · ​ · ​ · ​
​ · ​ · Years Ended December 31,
​​ ​ ​2025​ ​ ​2024
​ · ​ · (in millions)
Balance at beginning of period​$5.7​$4.0
Net increases to accruals​4.4​3.6
Warranty expenditures​(2.8)​(2.0)
Effect of changes in exchange rates​(0.1)​0.1
Balance at end of period​$7.2​$5.7

NOTE 5. INTANGIBLE ASSETS AND GOODWILL

Intangible assets consisted of the following:

​​​​​​​​​​​​
​ · ​ · December 31, 2025
​ · ​ ​ ​ · Gross Carrying · ​ ​ ​ · Accumulated · ​ ​ ​ · Net Carrying · ​ ​ ​ · Weighted Average Remaining
​ · ​ · Amount · ​ · Amortization · ​ · Amount · Useful Life (in years)
​ · ​ · (in millions) · ​ · ​
Technology​$101.8​$(78.2)​$23.6​6.6
Customer relationships​171.4​​(86.3)​85.1​7.7
Trademarks and other​27.3​​(18.3)​9.0​3.6
Total​$300.5​$(182.8)​$117.7​7.2
​​​​​​​​​​​​
​​December 31, 2024
​​ ​ ​Gross Carrying​ ​ ​Accumulated​ ​ ​Net Carrying​Weighted Average Remaining
​​Amount​Amortization​Amount​Useful Life (in years)
​​(in millions)​​
Technology​$99.9​$(70.0)​$29.9​7.0
Customer relationships​168.9​​(70.9)​98.0​8.5
Trademarks and other​27.1​​(15.6)​11.5​4.6
Total​$295.9​$(156.5)​$139.4​7.9

Amortization expense related to intangible assets was as follows:

​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​
​ · ​ · Years Ended December 31,
​​2025​ ​ ​2024​ ​ ​2023
​ · ​ · (in millions)
Amortization expense​$22.1​$26.0​$28.3

Estimated future amortization expense related to intangibles is as follows:

​​​​
Year Ending December 31,​ ​ ​​(in millions)
2026​$20.1
2027​17.8
2028​16.6
2029​15.0
2030​​13.4
Thereafter​34.8
Total​$117.7

The following table summarizes the changes in goodwill:

​​​​​​​
​ · ​ · December 31, · ​ · December 31,
​ · ​ · 2025 · ​ ​ ​ · 2024
​ · ​ · (in millions)
Balance at beginning of period​$296.0​$283.8
Additions from acquisition​​—​​16.1
Foreign currency translation and other​​4.8​​(3.9)
Balance at end of period​ ​ ​$300.8​$296.0

**NOTE 6.**LEASES

Components of total operating lease cost were as follows:

​​​​​​​​​​​
​ · ​ · ​ · Years Ended December 31,
​ · ​ ​ ​ · ​ · 2025 · ​ ​ ​ · 2024 · ​ ​ ​ · 2023
​ · ​ · ​ · (in millions)
Operating lease cost​​$25.7​$23.8​$22.6
Short-term and variable lease cost​​​5.7​​3.1​​4.2
Total operating lease cost​​$31.4​$26.9​$26.8

Estimated future payments on our operating lease liabilities are as follows:

​​​​
Year Ending December 31,​ ​ ​​(in millions)
2026​$22.9
2027​19.7
2028​19.4
2029​​16.1
2030​​14.6
Thereafter​​54.4
Total lease payments​​147.1
Less: Interest​​(35.6)
Present value of lease liabilities​$111.5

In addition to the above, we have a lease agreement with total payments of $6.4 million that commences in the first quarter of 2026 and extends through 2035.

The following tables present additional information about our lease agreements:

​​​​​​​​
​ · ​ · December 31, · ​ · December 31, · ​
​ · ​ ​ ​ · 2025 · ​ ​ ​ · 2024 · ​
Weighted average remaining lease term (in years)​ ​ ​​8.2​​8.4​
Weighted average discount rate​6.4%​6.1%
​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​
​ · ​ · Years Ended December 31,
​​ ​ ​2025​ ​ ​2024​2023
​ · ​ · (in millions)
Cash paid for operating leases​$26.8​$23.7​$23.0
Right-of-use assets obtained in exchange for operating lease liabilities​$19.7​$41.1​$14.3

NOTE 7. LONG-TERM DEBT

Long-term debt on our Consolidated Balance Sheets consists of the following:

​​​​​​​
​ · ​ · December 31, · ​ · December 31,
​ · ​ ​ ​ · 2025 · ​ ​ ​ · 2024
​ · ​ · (in millions)
Convertible Notes due 2028, 2.5% interest​$575.0​$575.0
Less: debt discount​​(7.5)​​(10.3)
Net long-term debt​​567.5​​564.7
Less: current maturities​​(567.5)​​—
Net long-term debt​$—​$564.7

For all periods presented, we were in compliance with the covenants under all debt agreements. As of December 31, 2025, our common stock traded above the conversion price for at least 20 trading days during a 30 consecutive trading-day period, which resulted in the Convertible Notes becoming convertible at the option of the holders. Accordingly, the Convertible Notes balance was reclassified from long-term to current debt as of December 31, 2025. We reassess the classification of the Convertible Notes at each quarterly reporting period, considering the trading price of our common stock relative to the conversion criteria. Exclusive of any early conversion elections by the convertible noteholders, there are no scheduled debt maturities until 2028

The following table summarizes interest expense related to our debt:

​​​​​​​​​​​
​ · ​ · ​ · Years Ended December 31,
​ · ​ ​ ​ · ​ · 2025 · ​ ​ ​ · 2024 · ​ ​ ​ · 2023
​ · ​ · ​ · (in millions)
Interest expense​​$13.6​$22.0​$15.2
Amortization of debt issuance costs​​​3.1​​3.2​​1.3
Total interest expense related to debt​​$16.7​$25.2​$16.5

Credit Agreement

On May 8, 2025, we terminated our prior credit agreement, dated as of September 10, 2019 (and subsequently amended) and entered into a new credit agreement (the “Credit Agreement”) consisting of a senior unsecured term loan facility (“Term Loan Facility”) and a senior unsecured revolving facility (“Revolving Facility”), both maturing on May 8, 2030. The maturity date may be accelerated to the date that is 91 days prior to the maturity date of our $575.0 million aggregate principal amount of 2.50% convertible senior notes due September 15, 2028 (the “Convertible Notes”), if the sum of our consolidated cash and cash equivalents plus the undrawn balance on the Revolving Facility is less than 120% of the redemption amount of the Convertible Notes.

The financing terms of the new Credit Agreement are substantially the same as the terms of the prior credit agreement. As part of the new credit facility, HSBC Bank USA, N.A. (“HSBC”) was appointed as the administrative agent for the lender group.

In connection with the Credit Agreement, we paid $1.9 million in lender and professional fees, which were capitalized and will be amortized over the term of the Credit Agreement.

At the time of termination, no borrowings were outstanding under the prior credit agreement, and there have beenno borrowings under the Credit Agreement to date. As of December 31, 2025, we had $600.0 million available on the Revolving Facility.

​ · ​ · ​ · ​ · ​ · ​ · ​
​​December 31,​December 31,
​​ ​ ​2025​ ​ ​2024
​ · ​ · (in millions)
Available capacity on Revolving Facility​$600.0​$600.0

In addition to our available capacity on the Revolving Facility, prior to the maturity date of the Credit Agreement, we may request an increase to the financing commitments in either the Term Loan Facility or Revolving Facility by an aggregate amount not to exceed $250.0 million. Any requested increase is subject to lender approval.

Should we have future borrowings under the Term Loan Facility or Revolving Facility, they will bear interest, at our option, at a rate based on the Base Rate or SOFR, as defined in the Credit Agreement, plus an applicable margin.

Convertible Senior Notes due 2028

On September 12, 2023, we completed a private, unregistered offering of the Convertible Notes. The remaining outstanding principal amount of the Convertible Notes, amounting to $567.5 million, net of unamortized issuance costs, was classified as current as of December 31, 2025. Pursuant to the indenture governing the Convertible Notes, because the last reported sale price of the Company’s common stock for at least 20 trading days during the period of 30 consecutive trading days ending on December 31, 2025 was greater than or equal to $179.76 on each applicable trading day, the holders have the right to surrender any portion of their Convertible Notes (in minimum denominations of $1,000 in principal amount or an integral multiple thereof) for conversion during the calendar quarter ending March 31, 2026, and only during such calendar quarter.

The Convertible Notes mature on September 15, 2028, unless earlier repurchased, redeemed, or converted. Interest is payable semi-annually in arrears in March and September. We do not maintain a sinking fund.

We may redeem for cash all or any portion of the Convertible Notes, at our option, on or after September 20, 2026 if the last reported sale price of our common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading-day period (including the last trading day of such period). The redemption price is 100% of the principal amount plus accrued and unpaid interest.

Prior to May 15, 2028, holders have the option to convert all or a portion of their Convertible Notes under the following circumstances:

●during any calendar quarter if the last reported sale price of our common stock, for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days is greater than or equal to 130% of the conversion price on each applicable trading day;
●during the five business day period immediately after any five consecutive trading day period in which the trading price per $1,000 principal amount of the Convertible Notes for each trading day was less than 98% of the product of the last reported sale price of our common stock on each such trading day and the conversion rate on each such trading day;
●if Advanced Energy calls any or all of the Convertible Notes for redemption; or
●upon the occurrence of specified corporate transactions or events described in the indenture.

From May 15, 2028 through the maturity date, holders have the option to convert at any time regardless of circumstances.

The initial conversion rate is 7.2747 shares of common stock per $1,000 principal amount, which is equivalent to an initial conversion price of approximately $137.46 per share of common stock. The conversion rate is subject to adjustment upon the occurrence of certain specified events as set forth in the indenture.

Upon conversion, Advanced Energy will do the following:

●pay cash up to the aggregate principal amount to be converted; and
●pay or deliver cash, shares of our common stock, or a combination (at our election) with respect to the remainder, if any, of the conversion obligation in excess of the aggregate principal amount being converted.

Concurrent with the Convertible Notes issuance, we entered into hedges (“Note Hedges”) with respect to our common stock and sold warrants to purchase our common stock (“Warrants”). In combination, the Note Hedges and Warrants synthetically increase the initial conversion price on the Convertible Notes from $137.46 to $179.76, reducing the potential dilutive effect.

The Warrants provide the counterparties the option to acquire approximately 4.2 million aggregate shares of our common stock (subject to customary anti-dilution adjustments), which is the same number of shares of our common stock covered by the Note Hedges at a$179.76 per share initial exercise price, which represents a 70% premium over the$105.74 closing price of our common stock on September 7, 2023. The Warrants expire on July 7, 2029.

If the market value per share of our common stock exceeds the exercise price of the Warrants during the measurement period at the maturity of such Warrants, the Warrants will have a dilutive effect on our earnings per share as we will owe the counterparties a number of shares of common stock in an amount based on the excess of such market price per share of the common stock over the Warrants’ exercise price.

The Note Hedge and Warrants are separate from the Convertible Notes. The Convertible Notes holders have no rights with respect to the Note Hedges and Warrants. Counterparties in the Note Hedge and Warrants transactions have no rights with respect to the Convertible Notes.

We use level 2 measurements to estimate the fair value of our debt. As of December 31, 2025 and 2024, we estimated the fair value of our Convertible Notes to be $951.1 million and $624.6 million, respectively.

NOTE 8. STOCKHOLDERS’ EQUITY AND EARNINGS PER SHARE

Accumulated Other Comprehensive Income (Loss)

The following table summarizes the components of, and changes in, accumulated other comprehensive income (loss), net of income taxes.

​​​​​​​​​​​​​
​​ ​ ​​Foreign Currency Translation​ ​ ​​Change in Fair Value of Cash Flow Hedges​ ​ ​​Defined Employee Benefit Plan​ ​ ​​Total
​ · ​ · (in millions)
Balance at December 31, 2022​$(12.8)​$11.8​$17.3​$16.3
Other comprehensive income (loss) prior to reclassifications​​2.0​​4.6​​(5.5)​​1.1
Amounts reclassified from accumulated other comprehensive income​​—​​(10.9)​​(0.4)​​(11.3)
Balance at December 31, 2023​$(10.8)​$5.5​$11.4​$6.1
Other comprehensive income (loss) prior to reclassifications​​(13.1)​​2.2​​(0.7)​​(11.6)
Amounts reclassified from accumulated other comprehensive loss​​1.6​​(7.7)​​(0.2)​​(6.3)
Balance at December 31, 2024​$(22.3)​$—​$10.5​$(11.8)
Other comprehensive income (loss) prior to reclassifications​​15.1​​—​​—​​15.1
Amounts reclassified from accumulated other comprehensive income (loss)​​0.1​​—​​2.8​​2.9
Balance at December 31, 2025​$(7.1)​$—​$13.3​$6.2

Amounts reclassified from accumulated other comprehensive income (loss) to the specific caption within the Consolidated Statements of Operations were as follows:

​​​​​​​​​​​​
​ · ​ · Years Ended December 31, · ​ · To Caption on Consolidated
​ · ​ ​ · 2025 · ​ ​ · 2024 · ​ ​ ​ · 2023 · ​ ​ · Statements of Operations
​ · ​ · (in millions) · ​ · ​
Foreign currency translation​$(0.1)​$(1.6)​$—​Other income (expense), net
Cash flow hedges​​—​​7.7​​10.9​Interest expense
Defined employee benefit plan​(2.8)​0.2​0.4​Other income (expense), net
Total reclassifications​$(2.9)​$6.3​$11.3​​

Earnings Per Share

The following table summarizes our earnings per share (“EPS”):

​​​​​​​​​​
​ · ​ · Years Ended December 31,
​ · ​ ​ ​ · 2025 · ​ ​ ​ · 2024 · ​ ​ ​ · 2023
​ · ​ · (in millions, except per share amounts)
Income from continuing operations​$149.3​$56.3​$130.8
​​​​​​​​​​
Basic weighted-average common shares outstanding​37.6​37.5​37.5
Dilutive effect of Convertible Notes​​0.4​​—​​—
Dilutive effect of Warrants​​0.1​​—​​—
Dilutive effect of stock awards​0.5​0.3​0.3
Diluted weighted-average common shares outstanding​38.6​37.8​37.8
​​​​​​​​​​
​​​​​​​​​​
EPS from continuing operations​​​​​​
Basic EPS​$3.97​$1.50​$3.49
Diluted EPS​$3.87​$1.49​$3.46
​​​​​​​​​​
​​​​​​​​​​
Anti-dilutive shares not included above​​​​​​​​​
Warrants​​1.5​​3.0​​3.5

Anti-dilutive stock awards rounded to zero for the periods presented.

We compute basic earnings per share of common stock (“Basic EPS”) by dividing income available to common stockholders by the weighted-average number of common shares outstanding during the period.

SeeNote 7. Long-Term Debtfor information regarding our Convertible Notes, Note Hedges, and Warrants. For diluted earnings per share of common stock (“Diluted EPS”), we increase the weighted-average number of common shares outstanding during the period, as needed, to include the following:

●Additional common shares that would have been outstanding if our outstanding stock awards had been converted to common shares using the treasury stock method. We exclude any stock awards that have an anti-dilutive effect;
●Dilutive impact associated with the Convertible Notes using the if-converted method. The Convertible Notes are repayable in cash up to par value and in cash or shares of common stock for the excess over par value. When the stock price is lower than the strike price, there is no dilutive or anti-dilutive impact. When the stock price is higher than the initial strike price, there is a dilutive impact associated with the Convertible Notes. Prior to conversion, we do not consider the Note Hedges for purposes of Diluted EPS as their effect would be anti-dilutive. Upon conversion, we expect the Note Hedges to offset the dilutive effect of the Convertible Notes when the stock price is above $137.46 but below $179.76; and
●Dilutive effect of the Warrants issued concurrently with the Convertible Notes using the treasury stock method. For the fourth quarter of 2025, the Warrants increased the weighted-average number of common shares outstanding because the average market price of our common stock exceeded the $179.76 exercise price of the Warrants.

Share Repurchases

To repurchase shares of our common stock, we periodically enter into share repurchase agreements. The following table summarizes these repurchases:

​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​
​ · ​ · Years Ended December 31,
​​ ​ ​2025​ ​ ​2024​ ​ ​2023
​ · ​ · (in millions, except per share amounts)
Amount paid or accrued to repurchase shares​$30.4​$1.8​$40.1
Number of shares repurchased​0.3​—​0.4
Average repurchase price per share​$96.79​$93.58​$105.74

There wereno shares repurchased from related parties. Repurchased shares were retired and assumed the status of authorized and unissued shares. At December 31, 2025, we had$0.2 million accrued in other accrued expenses in our Consolidated Balance Sheets for share repurchases.

At December 31, 2025, the remaining amount authorized by the Board of Directors (“our Board” or “the Board”) for future share repurchases was$166.9 million with no time limitation.

NOTE 9. FAIR VALUE MEASUREMENTS

Refer toNote 12. Employee Retirement Plans and Post Retirement Benefits for information on fair value of our pension asset and liabilities. The following tables present information about our non-pension assets and liabilities measured at fair value on a recurring basis. We classify all items below within level 2 of the fair value hierarchy. SeeNote 7. Long-Term Debt for information regarding the fair value of our Convertible Notes.

​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​
​​​​December 31,​December 31,
​​ ​ ​​​ ​ ​2025​ ​ ​2024
Description · ​ · Balance Sheet Classification · ​ · (in millions)
Certificates of deposit​Other current assets​$0.2​$0.2
Foreign currency forward contracts​Other accrued expenses​$0.1​$0.3
Investments​Other assets​$13.5​$9.9
Deferred compensation liabilities​Other liabilities​$13.4​$10.1

NOTE 10. DERIVATIVE FINANCIAL INSTRUMENTS

Changes in foreign currency exchange rates impact our results of operations and cash flows. We may manage these risks through the use of derivative financial instruments, primarily forward contracts with banks. These forward contracts manage the exchange rate risk associated with assets and liabilities denominated in nonfunctional currencies. Typically, we execute these derivative instruments for one-month periods and do not designate them as hedges for accounting purposes; however, they do partially offset the economic fluctuations of certain of our assets and liabilities due to foreign exchange rate changes.

The gains and losses related to these foreign currency exchange contracts are intended to offset the corresponding gains and losses on the revaluation of the underlying assets and liabilities. Both are included as a component of other income (expense), net in our Consolidated Statements of Operations.

As of December 31, 2025 and 2024, we had $60.5 million and $70.6 million, respectively, of foreign currency forward contracts outstanding.

SeeNote 9. Fair Value Measurements for information regarding the fair value of derivative instruments.

As a result of using derivative financial instruments, we are exposed to the risk that counterparties to contracts could fail to meet their contractual obligations. We manage this credit risk by reviewing counterparty creditworthiness on a regular basis and limiting exposure to any single counterparty.

NOTE 11. RESTRUCTURING, ASSET IMPAIRMENTS, AND OTHER CHARGES

Details of restructuring, asset impairments, and other charges are as follows:

​​​​​​​​​​
​ · ​ · Years Ended December 31,
​ · ​ · 2025 · ​ ​ ​ · 2024 · ​ ​ ​ · 2023
​ · ​ · (in millions)
Restructuring​$6.3​$28.1​$25.1
Asset impairments​​1.8​​—​​1.4
Other charges​4.4​2.2​0.5
Total restructuring, asset impairments, and other charges​$12.5​$30.3​$27.0

Restructuring

We have several restructuring plans in process. The amounts incurred as a result of the approved actions are estimates, and actual results may differ, which could result in incremental restructuring charges in future periods.

2025 Plan

During the second quarter of 2025, we approved actions related to consolidating our research and development, sales, and administrative functions in connection with our manufacturing and footprint consolidation (the “2025 Plan”). We expect these actions to be substantially complete during 2027 and do not expect to incur significant additional charges.

2024 Plan

In 2024, we approved actions in furtherance of our manufacturing consolidation initiatives intended to optimize our manufacturing footprint and cost structure, including the closure of our Zhongshan, China manufacturing facility (the “2024 Plan”). Manufacturing operations in Zhongshan ceased during the second quarter of 2025. Final closure activities are in progress and expected to conclude in 2026. We do not expect to incur significant additional charges.

2023 Plan

In 2023, we approved a plan intended to optimize and further consolidate our manufacturing operations and functional support groups as well as a general reduction-in-force to align our expenses to revenue levels (the “2023 Plan”). We expect final activities to conclude in the first quarter of 2027 and do not expect to incur significant additional charges.

2022 Plan

This plan was approved to improve our operating efficiencies and drive the realization of synergies from our business combinations by consolidating our operations, optimizing our factory footprint, including moving certain production into our higher volume factories, reducing redundancies, and lowering our cost structure. The 2022 Plan is now complete.

Changes in restructuring liabilities were as follows:

​​​​​​​​​​​​​​​​
​ · ​ ​ ​ · 2025 Plan · ​ ​ ​ · 2024 Plan · ​ ​ ​ · 2023 Plan · ​ ​ ​ · 2022 & Other Plans · ​ ​ ​ · Total
​ · ​ · (in millions)
December 31, 2023​$—​$—​$14.2​$3.1​$17.3
Costs incurred and charged to expense​​—​​29.6​​(1.6)​​0.1​​28.1
Costs paid​​—​​(5.1)​​(7.6)​​(3.2)​​(15.9)
Foreign currency translation​​—​​0.5​​—​​-​​0.5
December 31, 2024​​—​​25.0​​5.0​​(0.0)​​30.0
Costs incurred and charged to expense​​4.7​​1.1​​0.5​​—​​6.3
Costs paid​​(0.2)​​(22.6)​​(2.2)​​—​​(25.0)
Foreign currency translation​​—​​(0.1)​​(0.1)​​—​​(0.2)
December 31, 2025​$4.5​$3.4​$3.2​$(0.0)​$11.1

The above restructuring liability of $11.1 million is comprised of $6.3 million in other accrued expenses and $4.8 million included in other long-term liabilities on our Consolidated Balance Sheets.

Charges related to our restructuring plans are as follows:

​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​
​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​
​ · ​ · Years Ended December 31,
​​2025​ ​ ​2024​ ​ ​2023
​ · ​ · (in millions)
Severance and related charges​$6.3​$28.0​$25.1
Facility relocation and closure charges​—​0.1​—
Total restructuring charges​$6.3​$28.1​$25.1
​​​​​​​​​​​​​
​ · ​ · Cumulative Cost Through
​ · ​ · December 31, 2025
​ · ​ ​ ​ · 2025 Plan · ​ ​ ​ · 2024 Plan · ​ ​ ​ · 2023 Plan · ​ ​ ​ · Total
​ · ​ · (in millions)
Severance and related charges​ ​ ​$4.7​$30.7​$15.9​$51.3
Facility relocation and closure charges​​—​​0.1​​—​​0.1
Total restructuring charges​$4.7​$30.8​$15.9​$51.4

Asset Impairments

During 2025, we recorded $1.8 million of impairment charges in connection with vacating facilities.

Other Charges

Other charges relate to vacating and relocating facilities and personnel transition costs.

NOTE 12. EMPLOYEE RETIREMENT PLANS AND POSTRETIREMENT BENEFITS

Defined Contribution Plans

We have a 401(k) profit-sharing and retirement savings plan covering substantially all full-time U.S. employees. Participants may defer up to the maximum amount permitted by law. Participants are immediately vested in both their own contributions and profit-sharing contributions. Profit-sharing contributions, which are discretionary, are approved by the Board. For all periods presented, we based our profit-sharing contribution on matching 100% of employee contributions up to 3% of compensation plus an additional match of 50% on the next 2% of compensation.

During the years ended December 31, 2025, 2024, and 2023, we recognized total defined contribution plan costs of $5.1 million, $5.0 million, and $5.1 million, respectively.

Defined Benefit Plans

We maintain defined benefit pension plans for certain of our non-U.S. employees in the United Kingdom, Germany, and Philippines. Each plan is managed locally and in accordance with respective local laws and regulations.

In light of the United Kingdom’s High Court ruling in the case of Virgin Media Ltd v. NTL Pension Trustees II Ltd & Ors, we reviewed past amendments made to our United Kingdom pension plans. We continue to account for our United Kingdom pension plans in accordance with the plan agreements and amendments.

To measure the expense and related benefit obligation, we make various assumptions, including discount rates used to value the obligation, expected return on plan assets used to fund these expenses, and estimated future inflation rates. We base these assumptions on historical experience as well as current facts and circumstances. We use an actuarial analysis to measure the expense and liability associated with pension benefits.

The information provided below includes one pension plan which is part of discontinued operations. As such, for all periods presented, all related expenses are reported in discontinued operations in the Consolidated Statements of Operations.

Our projected benefit obligation and plan assets for defined benefit pension plans and the related assumptions used to determine the related liabilities are as follows:

​​​​​​​
​ · ​ · December 31, · ​ · December 31,
​ · ​ ​ ​ · 2025 · ​ ​ ​ · 2024
​ · ​ · (in millions)
Projected benefit obligation, beginning of year​$64.3​$65.7
Service cost​1.5​1.0
Interest cost​3.2​2.8
Actuarial loss (gain)​(2.6)​(0.4)
Benefits paid​(2.8)​(1.9)
Translation adjustment​4.1​(2.9)
Projected benefit obligation, end of year​​67.7​​64.3
​​​​​​​
Fair value of plan assets, beginning of year​$14.0​$14.1
Expected return​0.8​0.7
Contributions​1.7​1.6
Benefits paid​(1.9)​(1.4)
Actuarial gain (loss)​0.3​(0.6)
Translation adjustment​1.2​(0.4)
Fair value of plan assets, end of year​​16.1​​14.0
Funded status of plan​$(51.6)​$(50.3)
​ · ​ · ​ · ​ · ​ · ​ · ​
​​December 31,​December 31,
​​ ​ ​2025​ ​ ​2024
​ · ​ · (in millions)
Accumulated benefit obligation​$59.0​$55.9

The following table summarizes classification of our net pension benefit obligation on our Consolidated Balance Sheets. The current portion of the liability is included in accrued payroll and employee benefits.

​ · ​ · ​ · ​ · ​ · ​ · ​
​ · ​ · December 31,
​​ ​ ​2025​ ​ ​2024
​ · ​ · (in millions)
Current​$2.2​$0.7
Long-term​49.4​49.6
Total pension benefit obligation​$51.6​$50.3

The components of net periodic pension benefit cost recognized in our Consolidated Statements of Operations for the periods presented are as follows:

​​​​​​​​​​
​ · ​ · Years Ended December 31,
​ · ​ ​ ​ · 2025 · ​ ​ ​ · 2024 · ​ ​ ​ · 2023
​ · ​ · (in millions)
Service cost​$1.5​$1.0​$1.0
Interest cost​​3.2​​2.8​​2.9
Expected return on plan assets​(0.8)​(0.7)​(0.7)
Amortization of actuarial gains and losses​(0.3)​(0.2)​(0.4)
Net periodic pension cost​$3.6​$2.9​$2.8

Assumptions used in the determination of the net periodic pension cost are:

​ · ​ · ​ · ​ · ​ · ​ · ​ · ​
​ · ​ · Years Ended December 31,
​ · ​ ​ ​ · 2025 · ​ ​ ​ · 2024 · ​ ​ ​ · 2023
Discount rate used for net periodic pension costs5.0%4.4%5.1%
Discount rate used for pension benefit obligations​5.3%5.0%4.4%
Expected long-term return on plan assets5.8%5.9%5.2%

The fair value of our qualified pension plan assets by category was as follows:

​​​​​​​​​​​​​
​ · ​ · December 31, 2025
​ · ​ ​ ​ · Level 1 · ​ ​ ​ · Level 2 · ​ ​ ​ · Level 3 · ​ ​ ​ · Total
​ · ​ · (in millions)
Diversified Growth Fund​$—​$13.5​$—​$13.5
Corporate Bonds​—​​1.5​​—​​1.5
Insurance Contracts​​—​​—​​0.8​​0.8
Cash​0.3​​—​​—​​0.3
Total​$0.3​$15.0​$0.8​$16.1
​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​
​ · ​ · December 31, 2024
​ · ​ ​ ​ · Level 1 · ​ ​ ​ · Level 2 · ​ ​ ​ · Level 3 · ​ ​ ​ · Total
​ · ​ · (in millions)
Diversified Growth Fund​$—​$11.5​$—​$11.5
Corporate Bonds​—​1.3​—​1.3
Insurance Contracts​​—​—​0.7​0.7
Cash​0.5​—​—​0.5
Total​$0.5​$12.8​$0.7​$14.0

Expected future payments during the next ten years for our defined benefit pension plans are as follows:

​​​​
Year Ending December 31,​ ​ ​​(in millions)
2026​$3.9
2027​​3.8
2028​​3.4
2029​​4.8
2030​​4.5
2031 to 2035​​25.9

As of December 31, 2025 and 2024, accumulated other comprehensive income (loss) on the Consolidated Balance Sheets includes net actuarial gains and other deferred items, net of related taxes of $13.3 million and $10.5 million, respectively, that have not yet been recognized in net periodic pension cost.

NOTE 13. STOCK-BASED COMPENSATION

The Compensation Committee of our Board of Directors administers our stock plans. As of December 31, 2025, we havetwo active stock-based incentive compensation plans: the Amended and Restated 2023 Omnibus Incentive Plan (the “2023 Incentive Plan”) and the Employee Stock Purchase Plan (“ESPP”). We issue all new equity compensation grants under the 2023 Incentive Plan. Outstanding awards previously issued under inactive plans will continue to vest and remain exercisable in accordance with the terms of the respective plans.

The 2023 Incentive Plan provides for the grant of awards including stock options, stock appreciation rights, performance stock units, performance units, stock, restricted stock, restricted stock units, and cash incentive awards.

The following table summarizes information related to our stock-based incentive compensation plans:

​​​
​​December 31, 2025
​​(in millions)
Shares available for future issuance under the 2023 Incentive Plan​1.4
Shares available for future issuance under the ESPP​0.5

Stock-based Compensation Expense

We recognize stock-based compensation expense based on the fair value of the awards issued and the functional area of the employee receiving the award. For the year ended December 31, 2025, stock-based compensation expense includes $3.7 million related to the Airity acquisition (seeNote 2. Acquisition). Stock-based compensation expense was as follows:

​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​
​ · ​ · ​ · Years Ended December 31,
​​ ​ ​​ ​ ​2025​ ​ ​2024​ ​ ​2023
​ · ​ · ​ · (in millions)
Stock-based compensation expense​​$55.7​$45.9​$31.0

Restricted Stock Units

Generally, we grant restricted stock units (“RSUs”) with athree year time-based vesting schedule. Certain RSUs contain performance-based or market-based vesting conditions in addition to the time-based vesting requirements. RSUs are generally granted with a grant date fair value based on the market price of our stock on the date of grant. For RSUs that vest based on our relative total shareholder return over the performance period to a predetermined peer group, fair value is predetermined based on a Monte Carlo simulation as of the date of the grant.

Changes in our RSUs were as follows:

​ · ​ · ​ · ​ · ​ · ​
​ · ​ · Year Ended December 31, 2025
​ · ​ ​ ​ · ​ · ​ ​ ​ · Weighted-
​ · ​ · ​ · ​ · Average
​ · ​ · Number of · ​ · Grant Date
​ · ​ · RSUs · ​ · Fair Value
​ · ​ · (in millions) · ​ · ​
RSUs outstanding at beginning of period1.0​$95.05
RSUs granted0.5​$119.54
RSUs vested(0.4)​$87.26
RSUs forfeited(0.1)​$84.98
RSUs outstanding at end of period1.0​$111.72

For vested RSUs, employees withheld shares for income tax totaling $14.5 million.

The weighted-average grant date fair value for RSUs granted in the years ended December 31, 2025, 2024, and 2023 was $119.54, $104.84, and $100.04, respectively. The fair value of RSUs vested for the years ended December 31, 2025, 2024 and 2023 was $34.9 million, $28.2 million, and $19.5 million, respectively. As of December 31, 2025, there was $61.9 million of total unrecognized compensation cost, net of expected forfeitures, related to non-vested RSUs, that we expect to recognize through December 2028, with a weighted-average remaining vesting period of 1.0 years.

Stock Options

Generally, we grant stock option awards with an exercise price equal to the market price of our stock at the date of grant and with either athree orfour-year vesting schedule or performance-based vesting. Stock option awards generally have a term often years.

Changes in our stock options were as follows:

​ · ​ · ​ · ​ · ​ · ​ · ​ · ​
​ · ​ · Year Ended December 31, 2025
​ · ​ ​ ​ · ​ · ​ ​ ​ · Weighted- · ​ ​ ​ · Weighted-
​ · ​ · ​ · ​ · Average · ​ · Average
​ · ​ · Number of · ​ · Exercise Price · ​ · Remaining
​ · ​ · Options · ​ · per Share · ​ · Contractual Life
​ · ​ · (in millions) · ​ · ​ · ​ · ​
Options outstanding at beginning of period0.1​$83.05​6.86 years
Options exercised—​$80.70​​
Options outstanding at end of period0.1​$85.97​6.21 years
Options vested at end of period—​$85.97​6.21 years

The total intrinsic value of options exercised for the years ended December 31, 2025, 2024 and 2023 was $2.6 million, $0.8 million, and $4.6 million, respectively. As of December 31, 2025, the aggregate intrinsic value of options outstanding and exercisable was $4.4 million and $4.4 million, respectively. As of December 31, 2025, there wereno stock options outstanding or exercisable, andno remaining unrecognized compensation cost related to stock options.

Employee Stock Purchase Plan

The ESPP is a stockholder-approved plan that allows eligible employees to purchase our common stock at a discount. Employees who meet the eligibility criteria may contribute up to the lesser of 15% of their eligible earnings or $5,000 during each plan period. Currently, the plan period is six months. The purchase price of common stock purchased under the ESPP is currently equal to the lower of 1)85% of the fair market value of our common stock on the commencement date of each plan period or 2)85% of the fair market value of our common shares on each plan period purchase date.

As of December 31, 2025, there was $0.6 million of total unrecognized compensation cost related to the ESPP that we expect to recognize over a remaining period offive months.

Deferred Compensation Plan

We offer certain employees the opportunity to defer compensation and stock awards and maintain a rabbi trust in connection with this deferred compensation plan. Assets of the rabbi trust are consolidated as we are the primary beneficiary. Although we cannot use the rabbi trust’s assets for any purpose other than meeting our obligations under the deferred compensation plan, the trust’s assets, liabilities, and activity are included in our consolidated financial statements.

Assets of the rabbi trust not held in Company shares are presented in other assets, and the fair value of the Company shares held in the rabbi trust is classified in stockholders’ equity.

After a holding period, employees have the option to diversify the Company shares into other funds. Stock awards that have been elected for deferral but have not yet vested and are probable of vesting are reported as deferred compensation in the temporary equity section of the Consolidated Balance Sheets. The stock awards recorded in temporary equity are recognized at fair value, with any difference from stock based compensation recorded in retained earnings.

The following table summarizes information regarding the rabbi trust’s assets and liabilities:

​ · ​ · ​ · ​ · ​ · ​ · ​
​ · ​ · December 31,
​​2025​2024
Description · Balance Sheet Classification · (in millions)
InvestmentsOther assets$13.5​$9.9
Deferred compensation liabilitiesOther liabilities$13.4​$10.1
Stock awards elected for deferralTemporary equity$7.8​$3.5
Company shares of common stockStockholders equity$2.6​$0.9

NOTE 14. INCOME TAXES

The geographic distribution of pretax income from continuing operations was as follows:

​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​
​ · ​ · Years Ended December 31,
​​ ​ ​2025​ ​ ​2024​ ​ ​2023
​ · ​ · (in millions)
Domestic​$(54.2)​$(43.2)​$(17.5)
Foreign​222.9​95.6​140.0
Income from continuing operations, before income taxes​$168.7​$52.4​$122.5

The income tax provision (benefit) from continuing operations is summarized as follows:

​​​​​​​​​​​
​ · ​ · Years Ended December 31,
​ · ​ ​ ​ · 2025 · ​ ​ ​ · 2024 · ​ ​ ​ · 2023
​ · ​ · (in millions) · ​
Current: · ​ · ​ · ​ · ​ · ​ · ​ · ​
Federal​$(1.8)​$3.8​$13.4​
State​1.2​0.5​0.6​
Foreign​33.8​12.3​11.7​
Total current provision​​33.2​​16.6​​25.7​
​​​​​​​​​​​
Deferred:​​​​​​​
Federal​​(5.9)​​(1.4)​​(5.5)​
State​(0.3)​(0.1)​(1.0)​
Foreign​(7.6)​(19.0)​(27.5)​
Total deferred benefit​(13.8)​(20.5)​(34.0)​
​​​​​​​​​​​
Total income tax provision (benefit)​$19.4​$(3.9)​$(8.3)​
Effective tax rate​​11.5%​(7.4)%​(6.8)%

The principal causes of the difference between the federal statutory rate and the effective income tax rate for each of the years below are as follows:

​​​​​​​
​ · ​ · Years Ended December 31,
​ · ​ ​ ​ · 2024 · ​ ​ ​ · 2023
​ · ​ · (in millions)
Income taxes per federal statutory rate​$11.0​$25.9
State income taxes, net of federal deduction​​0.3​​(0.5)
U.S. tax on foreign operations​​18.9​​20.5
Foreign derived intangible income deduction​​(1.4)​​(2.9)
Tax effect of foreign operations​​(14.8)​​(28.1)
Uncertain tax positions​​(1.1)​​1.3
Change in valuation allowance assessment​​0.6​​(25.6)
Tax credits​​(7.8)​​(7.3)
Change in valuation allowance​​3.6​​12.9
Executive compensation limitation​​2.3​​2.0
Impact of intellectual property transfer​​(23.0)​​-
Other permanent items, net​​7.5​​(6.5)
Total income tax provision (benefit)​$(3.9)​$(8.3)
​​​​​​
​ · ​ · Years Ended December 31, · ​
​ · ​ ​ ​ · 2025 · ​
​​Tax Effect​Rate Effect​
​ · ​ · (in millions) · ​
U.S. Federal Statutory Tax Rate$35.4​21.0%
State and Local Income Taxes, Net of Federal Income Tax Effect​0.7​0.4%
Effect of Cross-Border Tax Laws​​​​​
Global intangible low-taxed income​17.3​10.2%
Other​0.8​0.5%
Tax Credits​​​​​
Foreign tax credit​(12.4)​(7.4)%
Research and development tax credits​(4.1)​(2.4)%
Nontaxable or Nondeductible Items​​​​​
Executive compensation limitation​3.2​1.9%
Other​(0.1)​(0.1)%
Other Adjustments​​​​​
Change in prepaid tax on intercompany profit​(2.8)​(1.6)%
Other​2.4​1.4%
Foreign Tax Effects​​​​​
Germany​​​​​
Effect of tax rate changes in the year​2.9​1.7%
Changes in valuation allowances​(3.1)​(1.9)%
Other​1.7​1.0%
Hong Kong​​​​​
Statutory rate difference​(3.3)​(2.0)%
Changes in valuation allowances​(9.2)​(5.4)%
Non-taxable income​(9.7)​(5.8)%
Withholding tax​1.7​1.0%
Other​0.9​0.5%
Pillar II​10.0​5.9%
Philippines​​​​​
Enterprise zone benefit​(3.1)​(1.8)%
Other​2.1​1.2%
Singapore​​​​​
Statutory rate difference​(4.7)​(2.8)%
Tax holiday​(4.8)​(2.9)%
Other​(3.7)​(2.1)%
Other Jurisdictions​1.8​1.2%
Changes in Unrecognized Tax Benefits​(0.5)​(0.2)%
Total$19.4​11.5%

The income taxes paid (net of refunds) is summarized as follows:

​​​
​​Year Ending
​​December 31, 2025
​​(in millions)
U.S. Federal$(6.5)
U.S. State & Local​(0.9)
Foreign​(13.4)
Total$(20.8)

From the above amounts, income taxes paid (net of refunds) exceed the 5% of taxes paid threshold in the following foreign jurisdictions. U.S. state and local jurisdictions did not exceed the 5% threshold.

​ · ​ · ​
​ · ​ · Year Ending
​ · ​ · December 31, 2025
​ · ​ · (in millions)
Foreign: · ​ · ​
Malaysia$(3.3)
Singapore$(2.6)
China$(2.3)
Philippines$(1.7)

From the above amounts, states that equal more than 50% of our state income taxes paid (net of refunds) but do not exceed the 5% of taxes paid include the following jurisdictions.

​ · ​ · ​
​ · ​ · Year Ending
​ · ​ · December 31, 2025
​ · ​ · (in millions)
U.S. State & Local: · ​ · ​
Texas$(0.3)
Tennessee$(0.3)

Deferred tax assets and liabilities are recognized for the future tax consequences of differences between the carrying amounts of assets and liabilities and their respective tax bases using enacted tax rates in effect for the year in which the differences are expected to be reversed. Significant deferred tax assets and liabilities consist of the following:

​​​​​​​
​ · ​ · December 31, · ​ · December 31,
​ · ​ ​ ​ · 2025 · ​ ​ ​ · 2024
​ · ​ · (in millions)
Deferred tax assets: · ​ · ​ · ​ · ​
Net operating loss and tax credit carryforwards​$85.6​$72.0
Pension obligation​8.1​9.2
Bond hedge original issue discount​15.2​20.2
Amortization​41.0​43.0
Operating lease liabilities​​15.1​​12.3
Other​54.4​56.5
Total deferred tax assets​219.4​213.2
Less: valuation allowance​(36.6)​(42.4)
Deferred tax assets, net of valuation allowance​182.8​170.8
​​​​​​​
Deferred tax liabilities:​​​​
Depreciation​2.4​2.5
Amortization​​23.6​​26.8
Unremitted earnings​4.1​2.8
Operating lease right-of-use assets​​12.5​​9.9
Operating lease liabilities​​1.5​​5.3
Other​1.6​2.7
Total deferred tax liabilities​45.7​50.0
​​​​​​​
Net deferred tax assets​$137.1​$120.8

Of the $137.1 million and $120.8 million net deferred tax assets as of December 31, 2025 and 2024, respectively, $137.7 million and $121.4 million, respectively, were included as a net non-current deferred tax asset within other assets on the Consolidated Balance Sheets. $0.6 million for both years were included as a net non-current deferred tax liability within other long-term liabilities on the Consolidated Balance Sheets.

During 2025, we completed a series of intercompany restructuring actions that created additional future taxable income that was previously not available in certain tax jurisdictions. Based on updated financial projections and planned business integration steps, these activities provided sufficient positive evidence to support the realization of deferred tax assets for which valuation allowances had previously been recorded. As a result, in 2025, we released deferred tax valuation allowances totaling $9.8 million with a corresponding decrease to tax expense. We will continue to update financial projections and integration plans on a periodic basis, and additional adjustments to the valuation allowance may be required in future periods.

As of December 31, 2025, we have recorded a total valuation allowance on $2.6 million of our U.S. domestic deferred tax assets, largely attributable to state carryforward attributes that are expected to expire before sufficient income can be realized in those jurisdictions. The remaining valuation allowance on deferred tax assets approximates $34.0 million and is associated primarily with operations in Hong Kong, China, and Switzerland. As of December 31, 2025, there is not sufficient positive evidence to conclude that such deferred tax assets, presently reduced by a valuation allowance, will more likely than not be recognized. For the year ended December 31, 2025, the valuation allowance decreased by $5.8 million.

As of December 31, 2025, we had U.S., foreign and state tax loss carryforwards of $28.4 million, $347.7 million, and $105.2 million, respectively. Additionally, we had $1.9 million and $30.5 million of capital loss and interest expense limitation carryforwards, respectively. Finally, we had U.S. and state tax credit carryforwards of $4.8 million and $2.0 million, respectively. The U.S. and state net operating losses, tax credits, and interest expense limitation are subject to various utilization limitations under Section 382 of the Internal Revenue Code and applicable state laws. These Section 382 limited attributes have various expiration periods through 2036 or, in the case of the interest expense limitation amount, no expiration period. Much of the foreign loss carryforwards, and $8.1 million of the federal net operating loss carry forwards, have no expiration period.

We operate under a tax holiday in Singapore. This tax holiday is in effect through June 30, 2027. The tax holiday is conditional upon our meeting certain employment and investment thresholds. The expected benefit of the tax holidays may be limited by the impact of Pillar II global minimum tax or other actions taken by these countries. For the years ended December 31, 2025, 2024 and 2023, the impact of the tax holidays decreased foreign taxes by $31.0 million, $12.4 million, and $14.3 million, respectively, and the benefit on earnings per diluted share was $0.82, $0.33, and $0.38, respectively.

We have undistributed earnings in certain foreign subsidiaries that we have indefinitely invested, and on which we have not recognized deferred taxes.

We account for uncertain tax positions by applying a minimum recognition threshold to tax positions before recognizing these positions in the consolidated financial statements. The following table provides a reconciliation of our total gross unrecognized tax benefits, which we include within other long-term liabilities on the Consolidated Balance Sheets:

​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​
​ · ​ · Years Ended December 31,
​​ ​ ​2025​ ​ ​2024​ ​ ​2023
​ · ​ · (in millions)
Balance at beginning of period​$5.7​$8.5​$7.5
Additions based on tax positions taken during a prior period​—​—​0.2
Additions based on tax positions taken during the current period​0.3​0.5​1.0
Reductions based on tax positions taken during a prior period​(0.2)​(2.1)​—
Reductions related to a lapse of applicable statute of limitations​(0.9)​(1.2)​(0.1)
Reductions related to a settlement with taxing authorities​—​—​(0.1)
Balance at end of period​$4.9​$5.7​$8.5

The unrecognized tax benefits of $4.9 million, if recognized, will impact our effective tax rate. In accordance with our accounting policy, we recognize accrued interest and penalties related to unrecognized tax benefits as a component of tax expense. We had $0.9 million and $0.8 million of accrued interest and penalties on December 31, 2025 and 2024, respectively. With few exceptions, we are no longer subject to federal, state, or foreign income tax examinations by tax authorities for years before 2022.

As of December 31, 2025, certain countries in which the Company operates have implemented or are in the process of implementing the Pillar II minimum global effective tax rate regime as put forth by the Organization for Economic Cooperation and Development (“OECD”). Specifically, the OECD released prospective “Side-by-Side” guidance in early 2026 which is generally beneficial to U.S. parented organizations, but will require adoption by member countries to implement. As countries continue to make revisions to their legislation and release additional guidance with respect to the global minimum tax, we continue to determine any potential cash tax expense and tax rate impact in the countries in which we operate.

On July 4, 2025, the One Big Beautiful Bill (“OBBB”) Act, which includes a broad range of elective tax law items available in 2025 and prescribed tax law changes in 2026, was signed into law in the United States. The Company

has reflected the impact of the OBBB’s elective tax law items in its financial statements for the period ending December 31, 2025.

NOTE 15. COMMITMENTS AND CONTINGENCIES

We are involved in disputes and legal actions arising in the normal course of our business. While we currently believe that the amount of any ultimate loss would not be material to our financial position, the outcome of these actions is inherently difficult to predict. In the event of an adverse outcome, the ultimate loss could have a material adverse effect on our financial position or reported results of operations. An unfavorable decision in intellectual property litigation also could require material changes in production processes and products or result in our inability to ship products or components found to have violated third party intellectual property rights. We accrue loss contingencies in connection with our commitments and contingencies, including litigation, when it is probable that a loss has occurred, and the amount of such loss can be reasonably estimated. We are not currently a party to any legal action that we believe would have a material adverse impact on our business, financial condition, results of operations or cash flows.

NOTE 16. SUPPLEMENTAL CASH FLOW INFORMATION

​​​​​​​​​​
​ · ​ · Years Ended December 31,
​ · ​ · 2025 · ​ · 2024 · ​ · 2023
​ · ​ · (in millions)
Non-cash investing activities:​​​​​​​​​
Capital expenditures in accounts payable and other accrued expenses​$30.6​$9.7​$9.0
Common stock used as consideration in business combination​$—​$4.5​$—
Cash paid for:​​​​​​​​​
Interest​$14.7​$17.3​$14.4
Income taxes​$24.1​$33.3​$47.9
Cash received from income taxes​$3.3​$3.8​$2.4
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.